InsidersTradesSigma
Track the Medivir AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Medivir AB has logged 1 public disclosures. Market capitalisation: €1bn. The latest transaction was reported on 3 December 2025 (Purchase). Among the most active insiders: Magnus Christensen. The full history is openly available.
Analysts rate Medivir AB Buy (bullish), based on 3 analysts. Average price target: SEK 4.98.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration